Netenax (Netilmicin)

Netilmicin, the active ingredient in Netenax, is an aminoglycoside antibiotic presented as an ophthalmic solution for ocular use. It is indicated for the treatment of bacterial eye infections such as conjunctivitis and keratitis, where it inhibits bacterial protein synthesis and helps resolve infection.

GNH USA supplies Netenax as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, providing reliable sourcing for regulated markets and ensuring compliance with quality standards.

Netenax is used in ophthalmology to treat bacterial infections of the eye.

Bacterial conjunctivitis: reduces bacterial load and alleviates symptoms of infection. Bacterial keratitis: eradicates causative organisms and promotes corneal healing. Other bacterial ocular surface infections: provides antibacterial coverage for susceptible pathogens.

Netenax may cause ocular and systemic adverse reactions, most of which are mild and transient.

Common Side Effects: - Stinging or burning sensation upon instillation. - Redness of the eye. - Increased tearing. - Blurred vision. - Mild eye irritation. - Temporary eyelid swelling.

Serious or Rare Side Effects: - Corneal ulceration. - Vision loss. - Severe allergic reaction (anaphylaxis). - Persistent ocular pain. - Endophthalmitis. - Systemic nephrotoxicity (rare with extensive absorption).

When prescribing Netenax, clinicians should consider the following precautions to ensure safe use.

Allergy assessment: confirm no known hypersensitivity to aminoglycosides or other ophthalmic components. Renal impairment: use with caution in patients with compromised kidney function, as systemic absorption may occur. Pregnancy and lactation: evaluate risk‑benefit, as safety data are limited. Contact lens wear: advise patients to remove lenses before administration and avoid wearing them until the eye is clear. Concurrent ototoxic drugs: monitor for additive toxicity if systemic aminoglycosides are used. Store at ambient temperature: keep below 25 °C, in the original container, protected from moisture and light.

Netenax can interact with other medicines, affecting efficacy or safety.

Major Interactions (Avoid): - Systemic aminoglycosides: concurrent use may increase risk of nephrotoxicity and ototoxicity. - Loop diuretics (e.g., furosemide): may potentiate ototoxic effects. - Neuromuscular blocking agents: may enhance neuromuscular blockade.

Moderate Interactions (Monitor Closely): - Topical corticosteroids: may mask signs of infection, requiring close monitoring. - Contact lens solutions containing preservatives: may increase ocular irritation.